July 2017
Volume 12 Issue 7 |
|
|
|
|
API Synthesis & Manufacturing
Cannabinoids have potential to treat a variety of diseases, but pharmaceutical companies must first develop cost-effective ways to access pharmaceutically pure materials without marijuana cultivation.
/ read more /
ASF plans to build a new world-scale ibuprofen production plant in Ludwigshafen and expand ibuprofen capacities at its Bishop, Texas plant.
/ read more /
|
|
|
Subscribe
Subscribers can enjoy each full issue of Pharmaceutical Technology in print or via the PharmTech app.
subscription offers |
 |
|
|
|
|
The Minneapolis Medical Research Foundation has contracted Avista to manufacture an opioid-derived small molecule as a component for a vaccine to treat opioid addiction.
/ read more /
By purchasing the BMS Sword, Ireland facility, SK Biotek will be the first South Korean company to invest in pharmaceutical manufacturing in Ireland.
/ read more /
|
|
|
ADVERTISEMENT
Pharmaceutical Technology's PharmaMarketplace
Your Connection to Global Pharmaceutical Manufacturing Suppliers
 Check it out today! |
|
|
|
Outsourcing Update
Despite the benefits of continuous processing adoption has been slow, except for a few process areas.
/ read more /
|
|
|
ADVERTISEMENT
Actionable Intelligence for Pharma Sourcing
Are you a pharmaceutical company with sophisticated sourcing needs? Or a biotech company looking for API/dose manufacturers? PharmSource provides timely, reliable intelligence and essential insights that will help you advance your business goals.
Learn more about  PharmSource STRATEGIC ADVANTAGE today. |
|
|
|
In the Lab
The company announced its new ISQ EC Single Quadrupole mass spectrometer and the new range of Thermo Scientific MAbPac RP 1-mm columns.
/ read more /
The company added new products to its InfinityLab LC Series which will be showcased at HPLC 2017 in Prague.
/ read more /
|
|
|
Supply Chain Update
A survey from The Pistoia Alliance found that just under a quarter (22%) of life-science companies are already using or experimenting with blockchain, but industry collaboration on security and storage standards is needed.
/ read more /
In new research conducted by SEA Vision and Zenith Technologies, 28% of respondents identified technology selection as the biggest challenge as the industry prepares to meet serialization deadlines.
/ read more /
|
|
|
Contract Services Update
Krinsky joined the board of directors at Halo after working for Teva Pharmaceuticals for 12 years.
/ read more /
The company announced that it has completed its 100th program using the pAVEway protein expression system, which was originally introduced to the market in 2007.
/ read more /
The company added a 40,000-ft2 purpose-built R&D center at 17112 Armstrong Ave, Irvine, CA.
/ read more /
The companies are partnering to provide new fill/finish facilities and solutions for biopharmaceutical products.
/ read more /
Aptar now manufactures its child-resistant pump, designed to meet US CPC requirements, at its facility in Congers, New York.
/ read more /
|
|
|
|
|
